Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha-Reference-Cited by-同舟云学术

Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha

Published:2010-03 Issue:3 Volume:57 Page:522-529
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roumeguère Thierry,Zouaoui Boudjeltia Karim,Babar Sajida,Nuyens Vincent,Rousseau Alexandre,Van Antwerpen Pierre,Ducobu Jean,Wespes Eric,Vanhaeverbeek Michel

Publisher

Elsevier BV

Subject

Urology

Reference51 articles.

1. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk;Roumeguère;Eur Urol,2003

2. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator;Solomon;Heart,2003

3. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease;Kang;Echocardiography,2002

4. The inflammation: lipoprotein cycle;Barter;Atheroscler,2005

5. The oxidative modification hypothesis of atherogenesis: an overview;Chisolm;Free Rad Biol Med,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial;World Journal of Urology;2022-07-08

2. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy;Pharmacology & Therapeutics;2021-11

3. The lipid paradox in neuroprogressive disorders: Causes and consequences;Neuroscience & Biobehavioral Reviews;2021-09

4. Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial;International Journal of Urology;2021-02-07

5. Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments;BMC Medicine;2020-10-19